TAMMY BAKER: Open Payments
NPI 1700260346 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,722 in 147 payments from 21 companies in 2025. Trend: 2023 $1,908 · 2024 $3,211 · 2025 $3,722
Food & beverage: $3,704Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $783 |
| Insmed, Inc. | 19 | $492 |
| GlaxoSmithKline, LLC. | 30 | $484 |
| Regeneron Healthcare Solutions, Inc. | 11 | $406 |
| GENZYME CORPORATION | 10 | $319 |
| Verona Pharma, Inc. | 10 | $210 |
| Merck Sharp & Dohme LLC | 6 | $182 |
| Grifols USA, LLC | 5 | $126 |
| JAZZ PHARMACEUTICALS INC. | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
Products named: DUPIXENT, Arikayce, TEZSPIRE, NUCALA, FASENRA, Ohtuvayre, AIRSUPRA, WINREVAIR.
Industry payments across FL — which companies pay providers there.
